Clinical Trial Update: Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial of pembrolizumab in incurable platinum-refractory germ cell tumors was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Neoplasms Female
• Genital Neoplasms Male
• Germ Cell Neoplasms
• Mediastinal Neoplasms
• Non-seminomatous Germ Cell Tumors
• Ovarian Neoplasms
• Testicular Neoplasms

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Nasser Hanna, M.D. | Conditions: Germ Cell Neoplasms, Testicular Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2018-04-17